vorherige Seite3 of 6nächste Seite
Financial Statements
Financial Statements

Bayer Group Consolidated Statements of Cash Flows

 3rd
Quarter
2007
3rd
Quarter
2008
First Nine
Months
2007
First Nine
Months
2008
€ million     
Income from continuing operations after taxes1,1802752,2491,618
Income taxes(769)133(221)701
Non-operating result266276741813
Income taxes paid(201)(197)(886)(913)
Depreciation and amortization7626502,0162,031
Change in pension provisions(116)(5)(298)(185)
(Gains) losses on retirements of noncurrent assets(8)(12)(2)(78)
Non-cash effects of the remeasurement of acquired assets
(inventory work-down)
5151164157
Gross cash flow1,1651,1713,7634,144
     
Decrease (increase) in inventories
(107)(299)(282)(563)
Decrease (increase) in trade accounts receivable397377(666)(697)
(Decrease) increase in trade accounts payable1(78)(97)(143)
Changes in other working capital, other non-cash items1676396(90)
Net cash provided by (used in) operating activities (net cash flow), continuing operations1,6231,2342,8142,651
Net cash provided by (used in) operating activities (net cash flow), discontinued operations (2)000
Net cash provided by (used in) operating activities
(net cash flow) (total)
1,6211,2342,8142,651
     
Cash outflows for additions to property, plant, equipment
and intangible assets
(482)(492)(1,123)(1,127)
Cash inflows from sales of property, plant, equipment
and other assets
8941120148
Cash inflows (outflows) from divestitures less divested cash(111)(3)4,792(52)
Cash inflows (outflows) for acquisitions less acquired cash
(198)(367)(455)(919)
Cash inflows (outflows) from noncurrent financial assets125973
Interest and dividends received96126565424
Cash (inflows) outflows from current financial assets23251
Net cash provided by (used in) investing activities (total)(603)(667)3,933(1,452)
     
Capital contributions----
Bayer AG dividend and dividend payments to minority stockholders0(2)(775)(1,042)
Issuances of debt2391031,8421,102
Retirements of debt
(1,555)(166)(7,051)(465)
Interest paid(222)(267)(1,207)(1,023)
Net cash provided by (used in) financing activities (total)(1,538)(332)(7,191)(1,428)
     
Change in cash and cash equivalents due to business activities (total)(520)235(444)(229)
     
Cash and cash equivalents at beginning of period2,9802,0582,9152,531
     
Change in cash and cash equivalents due to changes in scope
of consolidation
10(3)2
Change in cash and cash equivalents due to exchange rate
movements
(80)(12)(87)(23)
     
Cash and cash equivalents at end of period2,3812,2812,3812,281
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
Print page
Search
Search
Advanced Search
Download Center
 
 
Links
Annual Report 2007
 
Financial Reports
 
Comparison
Services
Order print version
 
Event Reminder
 
Press Newsletter
 
Would you like to be kept informed about new financial reports from Bayer?
 
SMS Service
Calendar
Investor Conference Call
Info
Notes on our information package and all services